JNJ

Johnson & Johnson · Healthcare · Drug Manufacturers - General
$240.10
+2.14 (+0.90%)
Mkt Cap: 578.62B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield3.9%
Dividend YieldN/A
Market Cap578.62B
Volume10.13M
Recent News
Johnson & Johnson (JNJ) Q1 2026 Earnings Call Transcript
seekingalpha.com · 2026-04-14
What Johnson & Johnson Earnings Signal for Healthcare ETFs
etftrends.com · 2026-04-14
What Makes a Healthcare Stock Worth Holding Through a Recession?
fool.com · 2026-04-14
Johnson & Johnson's Spravato sales growth signals upside for psychedelics peers like AtaiBeckley
proactiveinvestors.com · 2026-04-14
Johnson & Johnson: A 20% Gain Looks Easy After Q1 Earnings Results
marketbeat.com · 2026-04-14
Johnson & Johnson Q2 Earnings Review: Why You Should Be Buying The Stock Today
seekingalpha.com · 2026-04-14

Unlock the Full Deep Scan

9 AI agents analyze JNJ across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →